MedPath

PD1 gene polymorphism is associated with a poor prognosis in hepatocellular carcinoma following liver resectio

Not Applicable
Conditions
hepatocellular carcinoma
Registration Number
JPRN-UMIN000039950
Lead Sponsor
Hiroshima University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
321
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion for above statement.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary end point is overall survival.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath